INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT BETWEEN NXP B.V. AND NXP HOLDING 1 B.V. DATED AS OF FEBRUARY 7, 2010
Exhibit 10.42
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
*** Confidential Treatment has been requested for portions of this Exhibit. Confidential
portions of this Exhibit are designated by [****]. A complete version of this exhibit has been
filed separately with the Securities and Exchange Commission.
INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT
BETWEEN
NXP B.V.
AND
NXP HOLDING 1 B.V.
DATED AS OF
FEBRUARY 7, 2010
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
Table of Contents
(cont’d)
(cont’d)
Page(s) | ||||
ARTICLE I TERM AND TERMINATION |
2 | |||
1.1 Term |
2 | |||
1.2 No Termination of Agreement |
2 | |||
ARTICLE II TRANSFERS AND LICENSES |
3 | |||
2.1 Transfer and Assignment of Transferred IP |
3 | |||
2.2 Patent Licenses |
3 | |||
2.3 Licenses to Non-Patent Intellectual Property |
5 | |||
2.4 No Sublicensing |
6 | |||
2.5 Delivery. |
6 | |||
2.6 Assumed IP Contracts |
7 | |||
2.7 [****] |
7 | |||
2.8 Subsidiaries |
7 | |||
2.9 [****] |
7 | |||
2.10 Unidentified Contracts |
8 | |||
ARTICLE III INTELLECTUAL PROPERTY RIGHTS |
8 | |||
3.1 Transferred IP |
8 | |||
3.2 Patents |
8 | |||
3.3 Retained IP |
9 | |||
3.4 Acquired [****] Technology |
9 | |||
3.5 Prior Obligations |
9 | |||
3.6 Maintenance |
9 | |||
3.7 Trademarks |
9 | |||
3.8 Reasonable Assistance in Connection with Third Party Claims |
10 | |||
3.9 Other Limitations and Restrictions |
10 | |||
3.10 Composite and Component IP Blocks |
10 | |||
3.11 Covenants with Respect to Sublicenses |
10 | |||
3.12 Shared Masks |
10 | |||
ARTICLE IV CONFIDENTIALITY |
11 | |||
4.1 Trade Secrets and Confidential Information |
11 |
i
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
Table of Contents
(cont’d)
(cont’d)
Page(s) | ||||
4.2 Exceptions |
11 | |||
4.3 Source Code |
12 | |||
4.4 Terms of the Agreement |
12 | |||
ARTICLE V DEFINITIONS AND CONSTRUCTION |
12 | |||
5.1 Definitions |
12 | |||
5.2 Other Terms |
19 | |||
5.3 Interpretation |
19 | |||
ARTICLE VI MISCELLANEOUS |
19 | |||
6.1 No Implied Licenses |
19 | |||
6.2 Amendments and Waivers |
19 | |||
6.3 Entire Agreement |
19 | |||
6.4 Governing Law |
20 | |||
6.5 Submission to Jurisdiction; Selection of Forum; Waiver of Trial By Jury |
20 | |||
6.6 Notices |
20 | |||
6.7 Counterparts |
21 | |||
6.8 Severability |
21 | |||
6.9 Remedies |
22 | |||
6.10 Assignment |
22 | |||
6.11 [****] |
22 | |||
6.12 Independent Contractors |
22 | |||
6.13 Power and Authority |
22 | |||
6.14 Disclaimer |
22 | |||
6.15 Third Party Beneficiary Rights |
23 | |||
6.16 Section 365(n) |
23 | |||
6.17 Export Control |
23 |
Exhibits | ||||
Exhibit A: Form of Patent Assignment |
||||
Exhibit B: Form of Trademark Assignment |
||||
Exhibit C: NXP Logo and Trademark |
||||
Exhibit D: [****] |
ii
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
Table of Contents
(cont’d)
(cont’d)
Schedules | ||||
Schedule 2.1(b): Chain of Title |
||||
Schedule 3.8: Pending Litigation |
||||
Schedule 5.1(a): Assumed IP Contracts |
||||
Schedule 5.1(b): Exclusive IP Contracts |
||||
Schedule 5.1(c): Identified Exclusive IP Contracts |
||||
Schedule 5.1(d): Specified Exclusive IP Contracts |
||||
Schedule 5.1(e): Licensed NXP IP |
||||
Schedule 5.1(f) ME/MC Transferred Patents |
||||
Schedule 5.1(g): Retained ME/MC and Demod Patents |
||||
Schedule 5.1(h): Third Party IP |
||||
Schedule 5.1(i): Transferred Patents |
||||
Schedule 5.1(j): Transferred Technology |
||||
Schedule 5.1(k): Transferred Trademarks |
||||
Schedule 5.1(l): Trimedia Core |
||||
Schedule 5.1(m): Acquired [****] Technology |
||||
Schedule 5.1(n): Demod Transferred Patents |
||||
Schedule 5.1(o): Demod Transferred Technology |
||||
Schedule 5.1(p): Current NXP Car Products |
||||
Schedule 5.1(q): Video Decoding Transferred Patents |
||||
Schedule 5.1(r): CA Security Transferred Patents |
||||
Schedule 5.1(s): ME/MC Transferred Technology |
||||
Schedule 5.1(t): CA Security Transferred Technology |
||||
Schedule 5.1(u): Video Decoding Transferred Technology |
||||
Schedule 5.1(v): Retained Reliable Motion ME/MC Patents |
iii
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT
This Intellectual Property Transfer and License Agreement (“Agreement”) is made and
entered into, as of February 7, 2010 (the “Closing Date”), by and between NXP B.V., a
Dutch besloten venootshap (“NXP”), and NXP Holding 1 B.V., a Dutch besloten venootshap
(“Dutch Newco”).
RECITALS
WHEREAS, NXP and Trident Microsystems, Inc., a corporation organized under the laws of the
State of Delaware (“Trident”), have entered into that certain Share Exchange Agreement,
dated as of October 4, 2009 (the “Share Exchange Agreement”), pursuant to which NXP will
exchange all of the shares of the Transferred Newcos (as defined in the Share Exchange Agreement),
including Dutch Newco, as well as certain other assets and rights, for certain shares of common
stock, par value $0.001 per share, of Trident;
WHEREAS, pursuant to the terms and conditions of this Agreement, NXP shall transfer and
license certain Intellectual Property relating to the Business to Dutch Newco and Dutch Newco will
license certain of such Intellectual Property back to NXP;
WHEREAS, pursuant to the terms and conditions of this Agreement, NXP shall transfer certain
Trademarks relating to the Business to Dutch Newco without any right or license being granted back
to NXP pursuant to this Agreement;
WHEREAS, in consideration for the grants, transfers and assignments made by NXP to Dutch Newco
under this Agreement, Dutch Newco shall issue a promissory note to NXP for the fair market value of
the rights, transfers and assignments made by NXP to Dutch Newco pursuant to the terms set forth in
such promissory note; and
WHEREAS, the parties hereto desire to set forth the terms and conditions of such transfer and
license of Intellectual Property.
NOW THEREFORE, in consideration of the promises and mutual covenants and agreements contained
herein, the parties hereby agree as follows:
ARTICLE I
TERM AND TERMINATION
1.1 Term. The term of this License Agreement is perpetual, with the licenses
continuing for as long as the applicable Intellectual Property licensed hereunder exist. This
Agreement may only be terminated by mutual written agreement of the parties.
1.2 No Termination of Agreement. Each party acknowledges and agrees that its remedy
for breach by the other party or exceeding the scope of the licenses granted to it under this
Agreement, or of any other provision hereof, is to bring a claim to recover damages or to bring a
claim to seek injunctive relief for activities outside the scope of the applicable license
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
grants or both, but in no event is this Agreement terminable. A party may, in its discretion
as Licensee, terminate one or more of the licenses granted to it by written notice to the Licensor.
ARTICLE II
TRANSFERS AND LICENSES
2.1 Transfer and Assignment of Transferred IP.
NXP hereby sells, transfers, conveys, and assigns to Dutch Newco all right, title and interest
in and to the Transferred IP.
NXP hereby agrees to execute such documents of sale, transfer and assignment, including the
assignments substantially in the form attached hereto as Exhibits A (Form of Patent
Assignment) and B (Form of Trademark Assignment), and, at NXP’s expense, take such other
actions, in each case as may be reasonably requested by Dutch Newco to effect the sale, transfer
and assignment in and to the Transferred IP. Dutch Newco is responsible for registration and/or
recordation of the transfers and assignments hereunder, and the out-of-pocket fees paid to the US
Patent and Trademark Office or any other government intellectual property office in connection
therewith shall be shared equally by NXP and Dutch Newco, except that NXP shall bear 100% of the
out-of-pocket fees and reasonable expenses incurred in connection with addressing the chain of
title, recordation and other issues previously identified by Dutch Newco’s counsel, which issues
are generally identified on Schedule 2.1(b). NXP shall pay or reimburse Dutch Newco for
its portion of the fees within 30 days of the date of invoice.
It is understood and agreed that the only Patents being sold, transferred, conveyed and
assigned to Dutch Newco hereunder are the Transferred Patents.
2.2 Patent Licenses.
(a) Licenses to Dutch Newco.
(i) Retained Patents – Business Field. Subject to the terms and
conditions of this Agreement, NXP hereby grants to the Dutch Newco Group an
irrevocable, non-terminable, non-transferable (except as set forth in
Section 6.10 below), non-exclusive, fully-paid, royalty-free license, under
the Retained Patents and solely with respect to the Business Fields, to make (solely
for any member of the Dutch Newco Group), have made (solely for any member of the
Dutch Newco Group), use, sell, offer for sale, and import any products and to
practice any method or process in connection with the exercise of the foregoing
license, except that the license granted under this Section 2.2(a)(i) does
not extend to any [****].
(ii) Retained ME/MC and Demod Patents – All Fields. Subject to the
terms and conditions of this Agreement, NXP hereby grants to the Dutch Newco Group a
non-exclusive, irrevocable, non-terminable, non-transferable (except as set forth in
Section 6.10 below), fully-paid, royalty-free license, under the Retained
ME/MC and Demod Patents, to make, have made, use, sell, offer for
2
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
sale, and import
any products and to practice any method or process in connection with the exercise
of the foregoing license.
(iii) Retained Reliable Motion ME/MC Patents – All Fields and Exclusive
within Business Fields. Subject to the terms and conditions of this Agreement,
NXP hereby grants to the Dutch Newco Group an irrevocable, non-terminable,
non-transferable (except as set forth in Section 6.10 below), fully-paid,
royalty-free license, under the Retained Reliable Motion ME/MC Patents and with full
rights to sublicense with respect to the practice of the Retained Reliable Motion
ME/MC Patents in the Business Fields, to make, have made, use, sell, offer for sale,
and import any products and to practice any method or process in connection with the
exercise of the foregoing license. This license is exclusive with respect to the
Business Fields (even as to NXP and its Affiliates) and non-exclusive with respect
to all other fields.
(b) License to NXP.
(i) Demod Transferred Patents. Subject to the terms and conditions of
this Agreement and Section 7.10 of the Share Exchange Agreement, Dutch Newco hereby
grants to NXP and its Subsidiaries a non-exclusive, irrevocable, non-terminable,
non-transferable (except as set forth in Section 6.10 below), fully-paid,
royalty-free license, under the Demod Transferred Patents and solely with respect to
the NXP Fields, to make (solely for NXP or a NXP Subsidiary), have made (solely for
NXP or a NXP Subsidiary), use, sell, offer for sale, and import any TV Front End
Products and to practice any method or process in connection with the exercise of
the foregoing license.
(ii) ME/MC Transferred Patents. Subject to the terms and conditions of
this Agreement and Section 7.10 of the Share Exchange Agreement, Dutch Newco hereby
grants to NXP and its Subsidiaries, for use by the NXP Software business, a
non-exclusive, irrevocable, non-terminable, non-transferable (except as set forth in
Section 6.10 below), fully-paid, royalty-free license, under the ME/MC
Transferred Patents and solely with respect to the NXP Fields, to make (solely for
NXP or a NXP Subsidiary), have made (solely for NXP or a NXP Subsidiary), use, sell,
offer for sale, and import only software implementations that satisfy both of the
following requirements: (i) they are used solely in mobile phones and handsets and
(ii) they are NXP Software branded.
(iii) Current NXP Car Products. Subject to the terms and conditions of
this Agreement and Section 7.10 of the Share Exchange Agreement, Dutch Newco hereby
grants to NXP and its Subsidiaries a non-exclusive, irrevocable, non-terminable,
non-transferable (except as set forth in Section 6.10 below), fully-paid,
royalty-free license, under the Video Decoding Transferred Patents and ME/MC
Transferred Patents and solely with respect to the NXP Fields, to make (solely for
NXP or a NXP Subsidiary), have made (solely for NXP or a NXP Subsidiary), use, sell,
offer for sale, and import each Current NXP Car
3
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
Product and to practice any method
or process in connection with the exercise of the foregoing license.
(iv) NXP Patent Licensed Products. Subject to the terms and conditions
of this Agreement and Section 7.10 of the Share Exchange Agreement, Dutch Newco
hereby grants to NXP and its Subsidiaries a non-exclusive, irrevocable,
non-terminable, non-transferable (except as set forth in Section 6.10
below), fully-paid, royalty-free license, under the Other Transferred Patents and
solely with respect to the NXP Fields, to make (solely for NXP or a NXP Subsidiary),
have made (solely for NXP or a NXP Subsidiary), use, sell, offer for sale, and
import the NXP Patent Licensed Products and to practice any method or process in
connection with the exercise of the foregoing license.
2.3 Licenses to Non-Patent Intellectual Property.
(a) License to Dutch Newco. Subject to the terms and conditions of this
Agreement, NXP hereby grants to the Dutch Newco Group an irrevocable, non-terminable,
non-transferable (except as set forth in Section 6.10 below), non-exclusive,
perpetual, fully-paid, royalty-free license, solely with respect to the Business Fields, to
use, reproduce, display, perform, distribute, modify, prepare derivative works of and
otherwise exploit the Retained Technology as part of or in connection with the design,
development, manufacture, support and sale of products of any member of the Dutch Newco
Group.
(b) License to NXP.
(i) TV Front End Products. Subject to the terms and conditions of this
Agreement and Section 7.10 of the Share Exchange Agreement, Dutch Newco hereby
grants to NXP and its Subsidiaries, on a quitclaim basis, a non-exclusive,
irrevocable, non-terminable, non-transferable (except as set forth in Section
6.10 below), perpetual, fully-paid, royalty-free license, solely with respect to
the NXP Fields, to use, reproduce, display, perform, distribute, modify, prepare
derivative works of and otherwise exploit the Demod Transferred Technology as part
of or in connection with the design, development, manufacture, support and sale of
TV Front End Products.
(ii) Current NXP Car Products. Subject to the terms and conditions of
this Agreement and Section 7.10 of the Share Exchange Agreement, Dutch Newco hereby
grants to NXP and its Subsidiaries, on a quitclaim basis, a non-exclusive,
irrevocable, non-terminable, non-transferable (except as set forth in Section
6.10 below), perpetual, fully-paid, royalty-free license, solely with respect to
the NXP Fields, to use, reproduce, display, perform, distribute, modify, prepare
derivative works of and otherwise exploit the Video Decoding Technology, the ME/MC
Transferred Technology and the Shared Masks as part of or in connection with the
design, development, manufacture, support and sale of Current NXP Car Products.
4
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
(iii) NXP Technology Licensed Products. Subject to the terms and
conditions of this Agreement and Section 7.10 of the Share Exchange Agreement, Dutch
Newco hereby grants to NXP and its Subsidiaries, on a quitclaim basis, a
non-exclusive, irrevocable, non-terminable, non-transferable (except as set forth in
Section 6.10 below), perpetual, fully-paid, royalty-free license, solely
with respect to the NXP Fields, to use, reproduce, display, perform, distribute,
modify, prepare derivative works of and otherwise exploit the Other Transferred
Technology as part of or in connection with the design, development, manufacture,
support and sale of the NXP Technology Licensed Products.
2.4 No Sublicensing. Except as authorized by Section 2.2(a)(iii) of this
Agreement, each party hereby (a) agrees that it shall not sublicense any of the other party’s
Patents or Licensed Materials that are licensed hereunder, and (b) acknowledges that it receives no
right to grant any sublicenses.
2.5 Delivery.
(a) Obligations.
(i) At or as promptly as practicable after the Closing, NXP will deliver to
Dutch Newco any tangible or electronic copies of the Intellectual Property assigned
or licensed under this Agreement that are in the physical possession, custody or
control of NXP or its Subsidiaries at the Closing and not otherwise delivered in
connection with the transactions contemplated by the Share Exchange Agreement or
that Dutch Newco cannot locate following a reasonable search.
(ii) Upon request from time to time by NXP, a member of the Dutch Newco Group
will deliver any tangible or electronic copies of the Intellectual Property licensed
by Dutch Newco to NXP and its Subsidiaries under this Agreement that were, prior to
the Closing Date, owned or possessed by NXP and are assigned to Dutch Newco under
Section 2.1 of this Agreement, but only if and
to the extent that they were not retained by NXP or NXP cannot locate them
after a reasonable search and they are in the physical possession, custody or
control of Dutch Newco Group at the time of the request.
(iii) Dutch Newco is only obligated to deliver items in the form that they
exist as of the Closing Date. Without limitation, NXP is not entitled to receive
any modifications, derivative works or improvements to any such Intellectual
Property made by or for any member of Dutch Newco after the Closing Date.
(iv) Notwithstanding subparts (i) and (ii) above, NXP is not required to take
any action under Section 2.5(a)(i) on a request first made more than
twenty-four (24) months following the Closing Date, and Dutch Newco is not required
to take any action under Section 2.5(a)(ii) on a request first made more
than six (6) months following the Closing Date.
5
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
(v) The delivery in each case will be made by electronic or other means
mutually acceptable to NXP and Dutch Newco.
(vi) Dutch Newco is not entitled to receive any source code or related
documentation with respect to the Trimedia Core instruction set architecture that is
licensed to the Dutch Newco Group under Section 2.3.
(b) Relationship to R&D Services Agreement. This Section 2.5 does not apply to
any deliveries to be made under the R&D Services Agreement.
2.6 Assumed IP Contracts. Subject to Section 2.10, NXP hereby transfers and
assigns its and its Subsidiaries’ right in and to the Assumed IP Contracts. Dutch Newco hereby
accepts the assignment of the Assumed IP Contracts and assumes all Liabilities in respect thereof
arising after the Closing.
2.7 [****]
2.8 Subsidiaries. Any reference in this Agreement to a liability or obligation of a
party’s Subsidiary (or, in the case of Dutch Newco, any member of the Dutch Newco Group) shall be
deemed to incorporate a reference to an obligation on the part of that party to ensure that the
relevant liability is discharged or obligation is performed by the relevant Subsidiary or member of
the Dutch Newco Group, as the case may be. Any breach by the other party’s Subsidiary (or, in the
case of Dutch Newco, any member of the Dutch Newco Group) will be deemed a breach by the other
party. Any license granted to a party’s Subsidiary hereunder will terminate on the date that
Person ceases to be a Subsidiary of such party, and any license granted to any member of the Dutch
Newco Group hereunder will terminate on the date that Person ceases to be a member of the Dutch
Newco Group, except that, without limiting a
Licensor’s obligations under Section 6.11, during the period up to the ninetieth
(90th) day following the date on which a Person ceases to be a Subsidiary, upon that Person’s
request, Licensor shall use commercially reasonable efforts to negotiate a successor license with
that Person on commercial terms that are satisfactory to Licensor.
2.9 [****]
2.10 Unidentified Contracts. Notwithstanding anything in Section 2.6 or
2.7, Trident is not required to assume (and if Trident so elects, NXP shall retain and bear
the costs and expenses of) any IP Contract that was not identified to Trident and considered by
Trident and NXP by October 1, 2009, in generating the final financial model developed immediately
prior to the Agreement Date for the operation of Trident following the Closing (“Unidentified
Contracts”), provided that if such model reflected a basket or expense for such contracts, Trident
shall accept an aggregate liability for Unidentified Contracts up to the amount of such basket or
expense, and NXP shall retain and pay such liabilities in excess of such basket or expense.
6
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
ARTICLE III
INTELLECTUAL PROPERTY RIGHTS
3.1 Transferred IP. NXP agrees that, as between NXP and Dutch Newco, as of the
Closing, Dutch Newco is the sole and exclusive owner of all right, title and interest in and to the
Transferred IP, and that, under this Agreement, NXP acquires no right, title or interest in or to
any of the foregoing, other than the rights expressly granted hereunder.
3.2 Patents. To the extent that a license granted hereunder by a Licensor includes
the right to practice under one or more Patents that are part of the Transferred IP or Retained IP,
each such license includes not only Patents in existence as of the Closing Date that are part of
the Transferred IP or Retained IP, as the case may be, but also: (i) all subsequent divisions,
continuations, continuations-in-part (but these only to the extent based on inventions existing as
of the Closing Date), re-examinations, re-issues, provisionals, extensions and counterparts
relating thereto; (ii) all Patents issuing after the Closing Date that arise from inventions first
made, conceived or reduced to practice prior to the Closing Date that are part of the Transferred
IP or Retained IP, as the case may be; and (iii) all Patent claims entitled to the benefit of a
priority date from any of the foregoing Patents.
3.3 Retained IP. Dutch Newco agrees that, as between Dutch Newco and NXP, NXP is the
sole and exclusive owner of all right, title and interest in and to the Retained IP, and that under
this Agreement, Dutch Newco acquires no right, title or interest in or to any of the foregoing,
other than the rights expressly granted hereunder.
3.4 Acquired [****] Technology. Dutch Newco agrees, on behalf of itself and the Dutch
Newco Group, not to use any of the Acquired [****] Technology in connection
with the [****] and [****] markets until[****], and NXP, on behalf of itself and its
Affiliates, hereby covenants to the same.
3.5 Prior Obligations. Each party, as Licensee, acknowledges that all rights in or to
Intellectual Property and Trademarks granted by assignment, license or otherwise hereunder are
subject to (x) any rights granted to or retained by, and any restrictions validly imposed by, any
third party with respect to such Intellectual Property or Trademarks as of the Closing Date and (y)
any rights required to be granted to or retained by, and any restrictions to be validly imposed by,
any third party with respect to such Intellectual Property or Trademarks pursuant to obligations in
existence as of the Closing Date. This includes, without limitation, [****].
3.6 Maintenance. Licensor, in its sole discretion, shall have the sole right to
protect the Intellectual Property being licensed by it hereunder and nothing contained herein shall
be construed as obligating Licensor to file any patent or other intellectual property rights
application or to prosecute, maintain or enforce Intellectual Property licensed hereunder. Except
as set forth in Section 2.4 with respect to the delivery of the Intellectual Property
licensed or assigned under this Agreement, nothing contained in this Agreement shall be construed
as obligating Licensor to provide any maintenance, support or other services, materials or
information to Licensee.
7
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
3.7 Trademarks. Dutch Newco shall not use, including as or as part of any of its
trademarks, service marks, trade names, domain names or other commercial or corporate indicia,
after the Closing Date, any NXP Trademarks, including the element “NXP” or any derivate or
combination Trademark containing the element “NXP.” Notwithstanding the foregoing, each member of
the Dutch Newco Group shall have the right: (i) until the end of the Finished Goods Period (as
defined in the Manufacturing Services Agreement) to use the NXP Logo and Trademark (defined as the
trademark rights listed in Exhibit C hereto) on all product packing material with respect to the
Products (as defined in the Manufacturing Services Agreement), including labels, boxes, invoices,
and customs documents, and all related documentation, including manuals, brochures, data sheets,
collateral and other product related materials; (ii) to sell, transfer, import, export and/or ship
products bearing a NXP Trademark, which products were included in the Finished Goods and WIP (as
those terms are defined in the Share Exchange Agreement) or were sold under the Manufacturing
Services Agreement to Dutch Newco Group bearing an NXP Trademark, and without deleting, altering or
obscuring such Trademark; and (iii) on its and their websites, in marketing collateral, datasheets
and elsewhere to advise their actual and potential customers that the Business was acquired from
NXP. The foregoing rights granted under subparts (i) and (iii) are subject to NXP’s standard
Trademark usage guidelines, as they may be amended or modified from time to time, and NXP reserves
the right to practice quality control with regard to its marks.
3.8 Reasonable Assistance in Connection with Third Party Claims. In the event that,
as of the Closing Date, NXP or any of its Subsidiaries is contractually obligated to or
otherwise is under a legally binding obligation to indemnify or undertake the defense of any
third party in any action in which it is alleged that any of the Transferred IP infringes any third
party’s intellectual property rights and a third party makes a claim against NXP or any of its
Subsidiaries after the Closing Date or any such claim is pending as of the Closing Date (which
pending claims are listed on Schedule 3.8), then, at NXP’s request and expense, Dutch Newco
shall provide NXP with assistance as reasonably requested by NXP in connection with such
proceedings. In the event that Trident or Dutch Newco is contractually obligated to or otherwise is
under a legally binding obligation to indemnify or undertake the defense of any third party in any
action in which it is alleged that any of the Transferred IP infringes any third party’s
intellectual property rights and a third party makes a claim against Trident or Dutch Newco, then,
at Trident or Dutch Newco’s request and expense, NXP shall provide Trident or Dutch Newco with
assistance as reasonably requested by Trident or Dutch Newco in connection with such proceedings.
3.9 Other Limitations and Restrictions. Notwithstanding anything in this Agreement to
the contrary, no member of the Dutch Newco Group shall modify or create derivative works of the
Trimedia Core instruction set architecture that is licensed to the Dutch Newco Group under
Section 2.3.
3.10 Composite and Component IP Blocks. Trident acknowledges that the Intellectual
Property identified on Schedule 5.1(e) (the “Composite IP Blocks”) may be comprised
of sub-blocks and components, some of which may be Retained Technology or Third Party IP (those
sub-blocks and components, the “Component IP Blocks”). Trident acknowledges that, as of
the Closing, it owns all right, title and interest in and to the Composite IP Blocks, subject to
any rights that NXP or third parties may have in the underlying Component IP Blocks.
8
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
Likewise, NXP
acknowledges that it receives the license from Dutch Newco to Dutch Newco’s applicable Licensed
Materials subject to any rights third parties may have in the underlying Component IP Blocks, and
NXP alone is responsible for obtaining all rights and licenses from third parties necessary to use
any of Dutch Newco’s Licensed Materials.
3.11 Covenants with Respect to Sublicenses. Dutch Newco agrees that it and all
members of the Dutch Newco Group will comply with all of the applicable terms of any license
agreement with respect to which it is granted a sublicense hereunder or to which it may have rights
because of an affiliated relationship with NXP. Likewise, NXP, on behalf of itself and its
Affiliates, hereby covenants to the same with respect to any Assumed Contract under which it may
have rights because of an affiliated relationship with the Dutch Newco Group.
3.12 Shared Masks. Dutch Newco Group shall make and keep available to NXP and its
Subsidiaries the physical embodiments of the Shared Masks at Taiwan Semiconductor Manufacturing
Company (“TSMC”). Dutch Newco Group shall inform TSMC that NXP and its Subsidiaries have limited
license rights with respect to the Shared Masks and, at NXP’s expense, take such other actions as
NXP may reasonably request to provide NXP access
to such Shared Masks, which access is subject to the rules, limitations, policies and
requirements of TSMC.
ARTICLE IV
CONFIDENTIALITY
4.1 Trade Secrets and Confidential Information. Each party agrees that it and its
Subsidiaries shall (i) maintain in confidence the other party’s Confidential Information, (ii) not
use the other party’s Confidential Information (a) except as may be reasonably required in
connection with the performance of this Agreement by Dutch Newco or NXP, as the case may be, and
(b) except as may be reasonably required after the Closing Date (i) by Dutch Newco in connection
with the licensed use of any Retained Technology, or (ii) by NXP in connection with the licensed
use of any Transferred Technology, and (iii) disclose such Confidential Information only to those
Subsidiaries, agents, contractors, employees and potential or actual manufacturers, customers,
licensees and sublicensees who have a need to know the same for the receiving party to exploit the
benefits of the licenses granted to it hereunder and who agree in writing not to disclose such
Confidential Information to any unauthorized person, consistent with the confidentiality
obligations herein. Notwithstanding these restrictions, either party and its Subsidiaries may
produce products contemplated under this Agreement that inherently disclose the other party’s
Confidential Information, on condition that such party and its Subsidiaries has made commercially
reasonable efforts to avoid disclosing the other party’s Confidential Information in the products.
The receiving party will protect the disclosing party’s Confidential Information from unauthorized
use, access, or disclosure in the same manner as the receiving party protects its own confidential
or proprietary information of a similar nature and with no less than reasonable care. Each party
agrees and acknowledges that violation of these provisions by the receiving party (or third parties
receiving Confidential Information from any of them) will cause irreparable harm to the disclosing
party and that the disclosing party shall be entitled to seek an injunction or other temporary
relief in addition to the disclosing party’s other rights at law or in equity.
9
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
4.2 Exceptions. The obligations in Section 4.1 do not apply to any
information that (i) is already or, through no fault of the receiving party, becomes publicly
available; (ii) rightfully and lawfully comes into the possession of the receiving party from a
third party without the imposition of any duty of confidentiality by that third party and who was
authorized to make such disclosure; (iii) was independently developed by a party without reference
to or use of the Confidential Information of the other party; or (iv) was already lawfully known to
the receiving party at the time of disclosure by the disclosing party, except with respect to
Confidential Information of a disclosing party that was known to the receiving party prior to the
Closing Date due to (i) the ownership of the specific Confidential Information by the receiving
party prior to the Closing Date or (ii) the fact the employees of the receiving party were
employees of the disclosing party prior to the Closing Date. A party is allowed to disclose
Confidential Information if it is required to be disclosed as a matter of Law or pursuant to a
legal
proceeding or the rules of a recognized stock exchange, on condition that the receiving party
promptly notifies the disclosing party of any such requirement, discloses no more information than
it believes in good faith based on the advice of counsel is required and cooperates, at the
disclosing party’s request and expense, with all reasonable attempts by the disclosing party to
contest or limit the scope of the required disclosure and to obtain a protective order or similar
confidential treatment.
4.3 Source Code. Each Licensee will use the same degree of care and employ the same
procedural safeguards to protect the Licensor’s source code that it uses to protect its own most
valuable source code, but in no event less than reasonable care.
4.4 Terms of the Agreement. The parties agree that the terms of this Agreement are
considered Confidential Information of both parties. Notwithstanding the foregoing, each party
shall have the right to provide a copy of this Agreement in confidence to its Affiliates, advisors,
accountants, counsel, any bona fide potential investor, financing source, investment banker,
acquirer, merger partner or other potential financial or strategic partner, on condition that the
disclosure is (a) on a strictly limited, need-to-know basis, (b) when the disclosing party believes
that the transaction is reasonably likely to take place, and (c) on terms applicable to other
highly confidential or sensitive information disclosed by that party in connection with the
transaction and those terms prohibit disclosure, prohibit use for any purpose other than as
required for due diligence in connection with the potential transaction and provide for reasonable
care. A party may also disclose this Agreement under seal or equivalent non-public treatment in
connection with any litigation or other legal action concerning this Agreement.
ARTICLE V
DEFINITIONS AND CONSTRUCTION
5.1 Definitions. As used in this Agreement, the following capitalized terms shall
have the following meanings:
“Acquired [****] Technology” means the non-Patent Intellectual Property identified on
Schedule 5.1(m), [****]
10
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
“Affiliate” of any Person means any other Person directly or indirectly controlling or
controlled by, or under direct or indirect common control with such Person, except that, for
purposes of this Agreement, NXP will not be considered an Affiliate of any member of Dutch Newco
Group, and no member of Dutch Newco Group will be considered an Affiliate of NXP. A Person is
considered an Affiliate of another Person only for so long as that control exists. For purposes of
this definition, the term “control” (including the correlative meanings of the terms “controlled
by” and “under common control with”), as used with respect to any Person, means the possession,
direct or indirect, of the power to direct or cause the direction of the policies,
operations or activities of that Person, directly or indirectly, whether through the ownership
of, or right to vote, or to direct the manner of voting of, voting securities, by Law or agreement,
or otherwise.
“Agreement” has the meaning set forth in the Preamble.
“Agreement Date” has the meaning set forth in the Share Exchange Agreement.
“Ancillary Agreements” has the meaning set forth in the Share Exchange Agreement.
“Assumed IP Contracts” means the Contracts identified on Schedule 5.1(a).
“Bankruptcy Code” has the meaning set forth in Section 6.16.
“Business” has the meaning set forth in the Share Exchange Agreement.
“Business Day” has the meaning set forth in the Share Exchange Agreement.
“Business Fields” means any and all of the following markets worldwide:
(1) [****]
(2) [****]
(3) [****]
(4) [****]
[****]
“CA Security Transferred Patents” means the Patents listed on Schedule 5.1(r).
“CA Security Transferred Technology” means the Intellectual Property listed on
Schedule 5.1(t).
“Chosen Courts” has the meaning set forth in the Share Exchange Agreement.
“Closing” has the meaning set forth in the Share Exchange Agreement.
“Closing Date” has the meaning set forth in the Preamble.
11
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
[****]
“Company Products” has the meaning set forth in the Share Exchange Agreement.
“Component IP Blocks” has the meaning set forth in Section 3.10.
“Composite IP Blocks” has the meaning set forth in Section 3.10.
“Confidential Information” means any and all technical and non-technical information
either party provides the other hereunder that the receiving party knows or reasonably should know
is confidential to the disclosing party, including, without limitation, trade secrets, know-how,
firmware, designs, schematics, techniques, software code, technical documentation, specifications
and plans, whether in written, oral, graphic or electronic form. Notwithstanding the foregoing,
after the Closing Date, (i) all Transferred Technology (to the extent included within the
definition of “Confidential Information”) will be deemed the Confidential Information of Dutch
Newco, not NXP, and (ii) all Retained Technology (to the extent included within the definition of
“Confidential Information”) will be deemed the Confidential Information of NXP, not Dutch Newco.
“Contracts” has the meaning set forth in the Share Exchange Agreement.
“Copyrights” means the copyrights in works of authorship (including rights in
databases and other compilations of information, mask works and semiconductor device rights,
computer and electronic data processing programs, operating programs and software, flow charts,
diagrams, descriptive texts and programs and computer print-outs), registrations and applications
therefor, and all similar rights throughout the world, and all renewals, extensions, restorations
and reversions thereof.
“Current NXP Car Products” means the three NXP integrated circuit products listed on
Schedule 5.1(p), as such products exist on the Closing Date and their Natural Successors
and Derivatives.
“Demod Transferred Patents” means the Patents listed on Schedule 5.1(n).
“Demod Transferred Technology” means the Intellectual Property listed on
Schedule 5.1(o), including all associated copyrights and trade secrets.
[****]
“Divested Entity” means any former Subsidiary of a Licensee as and from the moment it
no longer qualifies as a Subsidiary hereunder because of a sale, conveyance or other transfer of
such Subsidiary, and any former unincorporated business or division of the Licensee as and from the
moment it is divested by the Licensee to a transferee that is not a Subsidiary of the Licensee.
“Dutch Newco” has the meaning set forth in the Preamble.
“Dutch Newco Group” means Dutch Newco and at and following the Closing, Trident and
its Subsidiaries.
12
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
[****]
“Exclusive IP Contracts” means the Contracts identified in Schedule 5.1(b).
“Governmental Authority” has the meaning set forth in the Share Exchange Agreement.
“Identified Exclusive IP Contracts” means those Contracts identified in
Schedule 5.1(c).
[****]
“Intellectual Property” means Patents, Copyrights, Trade Secrets and all other
intellectual property rights (other than Trademarks).
“Licensed NXP IP” means the Intellectual Property identified on Schedule
5.1(e).
“Licensed Materials” means either the Retained Technology or the Transferred
Technology, as the case may be.
“Licensee” shall mean NXP or Dutch Newco, or NXP’s Subsidiaries or any member of the
Dutch Newco Group, as the case may be, in its or any of their capacity as licensee hereunder.
“Licensor” shall mean NXP or Dutch Newco, or their respective Subsidiaries, as the
case may be, in its or any of their capacity as licensor hereunder.
“Manufacturing Services Agreement” has the meaning set forth in the Share Exchange
Agreement.
“ME/MC Transferred Patents” means the Patents listed on Schedule 5.1(f).
“ME/MC Transferred Technology” means the Intellectual Property listed on
Schedule 5.1(s).
“NXP” has the meaning set forth in the Preamble.
“NXP Fields” means [****]
“NXP Patent Licensed Products” means (a) for the automotive, software and TV front-end
fields, any products of NXP and its Subsidiaries (other than the Company Products), and (b) for all
other fields, the products of NXP and its Subsidiaries as of the Closing Date (other than the
Company Products), and products on the then-existing roadmap of NXP and its Subsidiaries as of the
Closing Date, the making, use, importing, offering for sale, sale or supply of which would, in the
absence of the license granted by this Agreement, infringe a patent of the Other Transferred
Patents, and Natural Successors and Derivatives of any of the foregoing.
“NXP Technology Licensed Products” means (a) TV Front-end Products, (b) software for
mobile phones and handsets, (c) any products of NXP and its Subsidiaries (other than the Company
Products) in the automotive field, and (d) the products of NXP and its Subsidiaries as of the
Closing Date (other than the Company Products), and products on the then-existing
13
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
roadmap of NXP
and its Subsidiaries as of the Closing Date, and Natural Successors and Derivatives of any of the
foregoing.
“NXP Trademarks” means all Trademarks of NXP or its Affiliates as of the Closing Date,
excluding any Trademarks acquired by Dutch Newco in connection with the Transaction.
[****]
“Natural Successors and Derivatives” means (a) for a software product, any subsequent
release of that product which constitutes a bug fix or error correction or contains other minor
variations, enhancements or improvements for which the licensor does not generally charge a
separate fee to its customers, and (b) for an integrated circuit product, any new versions of that
product which fixes bugs, shrinks geometry, improves yield, reduces power or improves device
performance, but does not contain new features or functionality.
[****]
“Other Transferred Patents” means all Transferred Patents other than the following
Patents: (i) the Demod Transferred Patents; (ii) the ME/MC Transferred Patents; (iii) the CA
Security Transferred Patents; and (iv) the Video Decoding Transferred Patents.
“Other Transferred Technology” means all Transferred Technology other than the
following: (i) Demod Transferred Technology; (ii) ME/MC Transferred Technology; (iii) CA Security
Transferred Technology; (iv) Video Decoding Transferred Technology, (v) the reference designs and
masks relevant to each of the Company Products, and (vi) all copyright and trade secret rights
associated with the items described in subparts (i) – (v) of this definition.
“Patents” means all patents (including utility and design patents, industrial designs
and utility models), rights in inventions, and the registrations, invention disclosures and
applications therefor, including divisions, supplementary protection certificates, continuations,
continuations-in-part, provisional and renewal applications, and any renewals, extensions, reissues
and re-examinations thereof.
[****]
“Person” has the meaning set forth in the Share Exchange Agreement.
[****]
[****]
“R&D Services Agreement” has the meaning set forth in the Share Exchange Agreement.
“Retained Reliable Motion ME/MC Patents” means the Patents listed on Schedule
5.1(v).
“Retained IP” means the Retained Technology and the Retained Patents.
14
CONFIDENTIAL TREATMENT REQUESTED — REDACTED COPY
“Retained Patents” means all Patents directly or indirectly owned or controlled (in
the sense of having the right to grant licenses or sublicenses thereunder of or within the scope
granted herein and without requiring payment of royalties or other consideration by NXP or any of
its Subsidiaries to an unaffiliated third party, unless Dutch Newco agrees to and satisfies such
payment obligations) by NXP or any of its Subsidiaries as of the Closing Date, other than
Transferred Patents.
“Retained ME/MC and Demod Patents” means the Patents listed on Schedule
5.1(g).
“Retained Technology” means all NXP Intellectual Property (other than Patents) that
(a) NXP or any of its Affiliates owns (after the assignment of the Transferred IP to Dutch Newco)
or controls (in the sense of having the right to grant licenses or sublicenses thereunder of or
within the scope granted herein and without requiring payment of royalties or other consideration
by NXP or any of its Subsidiaries to an unaffiliated third party, unless Dutch Newco agrees to and
satisfies such payments obligations) as of the Closing Date, and (b) is used in connection with the
development, manufacture, test, packaging, process architecture and know-how, reproduction,
distribution, modification, adaptation, display, performance, use, offer for sale or sale of the
Company Products prior to or as of the Closing Date. Retained Technology includes, without
limitation, the Licensed NXP IP.
“Shared Masks” means the mask works for the Current NXP Car Products and all
Intellectual Property rights thereto.
“Share Exchange Agreement” has the meaning set forth in the Recitals.
“SoC” has the meaning set forth in the Share Exchange Agreement.
[****]
“Subsidiary” of any Person shall mean any legal entity (a) the majority of whose
shares or other securities entitled to vote for election of directors (or other managing authority)
is now or hereafter owned or controlled by such Person either directly or indirectly or (b) that
does not have outstanding shares or securities, but the majority of the equity interest of which is
now or hereafter owned or controlled by such Person either directly or indirectly; except that, in
the case of both (a) and (b) above, the entity is a Subsidiary of that Person only for so long as
that ownership or control exists. For purposes of this Agreement, following the Closing, Dutch
Newco will be considered a Subsidiary of Trident and not of NXP and no member of Dutch Newco Group
will be considered a Subsidiary of NXP.
“Third Party IP” means the Intellectual Property licensed to NXP or its Subsidiaries
from third parties, the agreements for which are identified on Schedule 5.1(h). Third
Party IP includes all Exclusive IP Contracts.
“Trademarks” means trademarks, service marks, Internet domain names, logos, product
names and slogans, symbols, trade dress, assumed names, fictitious names, trade names, brand names,
business names, and any other form of trade identity and other indicia of origin, all applications
and registrations for the foregoing and any renewals thereof, and the goodwill associated therewith
and symbolized thereby.
15
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
“Trade Secrets” means trade secrets, including confidential business and technical
information, ideas, research and development, know-how, formulae, drawings, prototypes, models,
designs, schematics, technical data, engineering, production and other designs, drawings,
engineering notebooks, industrial models, specifications, business methods, customer lists and
supplier lists, and any information meeting the definition of a trade secret under the Uniform
Trade Secrets Act or other similar legislation governing protection of trade secrets anywhere in
the world.
“Transferred IP” means the Transferred Technology, the Transferred Patents and the
Transferred Trademarks.
“Transferred Patents” means the Patents listed on Schedule 5.1(i).
“Transferred Technology” means the Intellectual Property identified on Schedule
5.1(j), including all associated copyright and trade secret rights. The Transferred Technology
includes, for each entry in Schedule 5.1(j), all software (including RTL), firmware,
libraries, IP cores, functional blocks, GDS, netlists, timing specifications, specifications,
tools, test plans, test programs, characterization reports, validation reports, schematics,
designs, database tapes, algorithms and documentation. The Transferred Technology also includes
reference designs and masks relevant to each of the Company Products.
“Transferred Trademarks” means the Trademarks identified on Schedule 5.1(k).
“Trident” has the meaning set forth in the Recitals.
“Trimedia Core” means the IP core listed on Schedule 5.1(l).
“TV Front End Product” means an integrated circuit that receives a broadcast signal
via a tuner and demodulates that signal for purposes of display on a TV screen.
“Unassumed Exclusive IP Contracts” means those Exclusive IP Contracts that are not
Identified Exclusive IP Contracts.
“Unidentified Contracts” has the meaning set forth in the Share Exchange Agreement.
“Video Decoding Transferred Patents” means the Patents listed on Schedule
5.1(q).
“Video Decoding Transferred Technology” means the Intellectual Property listed on
Schedule 5.1(u).
[****]
5.2 Other Terms. Other terms may be defined elsewhere in the text of this Agreement
and, unless otherwise indicated, shall have such meaning throughout this Agreement.
5.3 Interpretation. When a reference is made in this Agreement to Exhibits, such
reference shall be to an Exhibit to this Agreement unless otherwise indicated. When a reference is
made in this Agreement to Sections, such reference shall be to a Section of this Agreement
16
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
unless otherwise indicated. When a reference is made in this Agreement to Articles, such
reference shall be to an Article of this Agreement unless otherwise indicated. The words
“include”, “include” and “including” when used herein shall be deemed in each case to be followed
by the words “without limitation.” The headings contained in this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of this Agreement. The
parties hereto agree that they have been represented by legal counsel during the negotiation and
execution of this Agreement and, therefore, waive the application of any law, regulation, holding
or rule of construction providing that ambiguities in an agreement or other document shall be
construed against the party drafting such agreement or document.
ARTICLE VI
MISCELLANEOUS
6.1 No Implied Licenses. Nothing contained in this Agreement shall be construed as
conferring any rights by implication, estoppel or otherwise, under any Intellectual Property or
Trademarks other than the rights expressly granted in this Agreement.
6.2 Amendments and Waivers. Any term or provision of this Agreement may be amended,
and the observance of any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively), only by a writing signed by the party hereto
to be bound thereby. The waiver by a party of any breach hereof or default in the performance
hereof shall not be deemed to constitute a waiver of any other default or any succeeding breach or
default. The failure of any party to enforce any of the provisions hereof shall not be construed
to be a waiver of the right of such party thereafter to enforce such provisions.
6.3 Entire Agreement. This Agreement, the exhibits and schedules hereto, the Share
Exchange Agreement and the other Ancillary Agreements constitute the entire understanding and
agreement of the parties hereto with respect to the subject matter hereof and thereof and supersede
all prior and contemporaneous agreements or understandings, inducements or conditions, express or
implied, written or oral, between the parties with respect hereto. The express terms hereof
control and supersede any course of performance or usage of the trade inconsistent with any of the
terms hereof.
6.4 Governing Law. The internal law, without regard for conflicts of laws principles,
of the State of New York shall govern the validity of this Agreement, the construction of its
terms, and the interpretation and enforcement of the rights and duties of the parties hereto. The rights and obligations of the parties under this Agreement will not be governed by the
provisions of the 1980 United Nations Convention on Contracts for the International Sale of Goods
or the United Nations Convention on the Limitation Period in the International Sale of Goods, as
amended.
6.5 Submission to Jurisdiction; Selection of Forum; Waiver of Trial By Jury. Each
party hereto agrees that it shall bring any action or proceeding in respect of any claim arising
out of or related to this Agreement or the transactions contained in or contemplated by this
Agreement exclusively in the Chosen Courts, and solely in connection with claims arising
17
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
under this Agreement (i) irrevocably submits to the exclusive jurisdiction of the Chosen
Courts, (ii) waives any objection to laying venue in any such action or proceeding in the Chosen
Courts, (iii) waives any objection that the Chosen Courts are an inconvenient forum or do not have
jurisdiction over any party hereto and (iv) agrees that service of process upon such party in any
such action or proceeding shall be effective if notice is given in accordance with Section
6.6 of this Agreement. Each party hereto irrevocably waives any and all right to trial by jury
in any legal proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby.
6.6 Notices. All notices and other communications required or permitted under this
Agreement shall be in writing and shall be either hand delivered in person, sent by facsimile, sent
by certified or registered first-class mail, postage pre-paid, or sent by internationally
recognized express courier service. Such notices and other communications shall be effective upon
receipt if hand delivered or sent by facsimile, three (3) days after mailing if sent by mail, and
one (1) day after dispatch if sent by express courier, to the following addresses, or such other
addresses as any party may notify the other party in accordance with this Section 6.6:
If to NXP:
NXP
High Xxxx Xxxxxx 00
0000 XX Xxxxxxxxx
Xxx Xxxxxxxxxxx
Fax: + 00 00 00 00000
Attention: Guido X.X. Xxxxxxx
High Xxxx Xxxxxx 00
0000 XX Xxxxxxxxx
Xxx Xxxxxxxxxxx
Fax: + 00 00 00 00000
Attention: Guido X.X. Xxxxxxx
With a copy (which shall not constitute notice) to:
NXP
0000 XxXxx Xxxxx
Xxx Xxxx, Xxxxxxxxxx 00000
Fax: x0 (000) 000-0000
Attention: Xxxxx X. Xxxxx
0000 XxXxx Xxxxx
Xxx Xxxx, Xxxxxxxxxx 00000
Fax: x0 (000) 000-0000
Attention: Xxxxx X. Xxxxx
and
Xxxxxxxx & Xxxxxxxx LLP
0000 Xxxxxxxxxxx Xxxx
Xxxx Xxxx, Xxxxxxxxxx 00000
Fax: x0 (000) 000-0000
Attention: Xxxxx X. Xxxxxx
0000 Xxxxxxxxxxx Xxxx
Xxxx Xxxx, Xxxxxxxxxx 00000
Fax: x0 (000) 000-0000
Attention: Xxxxx X. Xxxxxx
If to Dutch Newco:
NXP Holding 1 B.V.
0000 Xxxxxxx Xxxxx
Xxxxx Xxxxx, XX 00000
Fax: x0 (000) 000-0000
0000 Xxxxxxx Xxxxx
Xxxxx Xxxxx, XX 00000
Fax: x0 (000) 000-0000
18
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
Attention: Xxxxx Xxxxxxxxx
With a copy (which shall not constitute notice) to:
Trident Microsystems, Inc.
0000 Xxxxxxx Xxxxx
Xxxxx Xxxxx, XX 00000
Fax: x0 (000) 000-0000
Attention: Xxxxx Xxxxxxxxx
and
0000 Xxxxxxx Xxxxx
Xxxxx Xxxxx, XX 00000
Fax: x0 (000) 000-0000
Attention: Xxxxx Xxxxxxxxx
and
DLA Piper US LLP
0000 Xxxxxxxxxx Xxxxxx
Xxxx Xxxx Xxxx, XX 00000-0000
Fax: x0(000) 000-0000
Attention: Xxxxx Xxx
0000 Xxxxxxxxxx Xxxxxx
Xxxx Xxxx Xxxx, XX 00000-0000
Fax: x0(000) 000-0000
Attention: Xxxxx Xxx
6.7 Counterparts. This Agreement may be executed in any number of counterparts, each
of which shall be an original as regards any party whose signature appears thereon and all of which
together shall constitute one and the same instrument. This Agreement shall become binding when
one or more counterparts hereof, individually or taken together, shall bear the signatures of all
parties reflected hereon as signatories.
6.8 Severability. If any provision of this Agreement, or the application thereof,
shall for any reason and to any extent be invalid or unenforceable, then the remainder of this
Agreement and the application of such provision to other persons or circumstances shall be
interpreted so as reasonably to effect the intent of the parties hereto. The parties hereto
further agree to replace such void or unenforceable provision of this Agreement with a valid and
enforceable provision that shall achieve, to the extent possible, the economic, business and other
purposes of the void or unenforceable provision.
6.9 Remedies. Except as otherwise expressly provided herein, any and all remedies
herein expressly conferred upon a party hereunder shall be deemed cumulative with and not exclusive
of any other remedy conferred hereby or by law on such party, and the exercise of any one remedy
shall not preclude the exercise of any other. The parties agree that irreparable damage would
occur in the event that any of the provisions of this Agreement were not performed in accordance
with their specific terms or were otherwise breached. It is accordingly agreed that the parties
shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to
enforce specifically the terms and provisions hereof in any court having jurisdiction.
6.10 Assignment. This Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors, legal representatives and permitted assigns.
Neither party may assign any of its rights or delegate any performance under this Agreement, by
operation of Law or otherwise, without the prior written consent of the other party, which consent
shall not be unreasonably withheld or delayed, except that either party may transfer or assign its
rights under this Agreement without the consent of the other party: (a) to one or more
19
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
of its current Subsidiaries or an Affiliate created due to an internal reorganization; and/or
(b) to a third party merger partner or the purchaser in connection with a merger, consolidation or
sale of all or substantially all of its stock or assets or of any portions of its business to which
this Agreement relates. Any purported assignment made without the consent provided for in this
Section 6.10 is null and void.
6.11 [****]
6.12 Independent Contractors. Nothing contained in this Agreement shall be deemed or
construed as creating a joint venture or partnership between any of the parties hereto. No party
is by virtue of this Agreement authorized as an agent, employee or legal representative of any
other party. No party shall have the power to control the activities and operations of any other
and their status is, and at all times shall continue to be, that of independent contractors with
respect to each other. No party shall have any power or authority to bind or commit any other
party. No party shall hold itself out as having any authority or relationship in contravention of
this Section 6.12.
6.13 Power and Authority. Each party hereby represents and warrants to the other
party that it has full power and authority to enter into this Agreement and to grant the rights and
licenses set forth herein and has not executed, and will not execute, any agreement or other
instrument in conflict herewith.
6.14 Disclaimer. THE PARTIES ACKNOWLEDGE AND AGREE THAT, EXCEPT FOR THE EXPLICIT
REPRESENTATIONS CONTAINED IN SECTION 6.13 ABOVE AND FOR ANY REPRESENTATION OR WARRANTY
EXPRESSLY MADE BY NXP IN THE SHARE EXCHANGE AGREEMENT, THE ASSIGNMENTS AND TRANSFERS MADE AND LICENSES GRANTED
HEREUNDER ARE ON AN “AS IS” BASIS, NEITHER NXP NOR DUTCH NEWCO MAKES ANY REPRESENTATIONS OR
WARRANTIES OF ANY KIND IN CONNECTION WITH THIS AGREEMENT, AND NXP AND DUTCH NEWCO EACH HEREBY
EXPRESSLY DISCLAIM AND EXCLUDE ALL WARRANTIES, WHETHER STATUTORY, EXPRESS OR IMPLIED, INCLUDING,
WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE,
TITLE, AND NON-INFRINGEMENT. WITHOUT LIMITING THE FOREGOING, NEITHER PARTY MAKES ANY WARRANTY OR
REPRESENTATION THAT ANY MANUFACTURE, USE, IMPORTATION, OFFER FOR SALE OR SALE OF ANY PRODUCT OR
SERVICE WILL BE FREE FROM INFRINGEMENT OF ANY PATENT OR OTHER INTELLECTUAL PROPERTY RIGHT OF ANY
THIRD PARTY OR AS TO THE VALIDITY AND/OR SCOPE OF ANY PATENT LICENSED BY SUCH PARTY TO THE OTHER
PARTY UNDER THIS AGREEMENT OR A WARRANTY OR REPRESENTATION THAT A PARTY WILL ENFORCE ANY PATENT
AGAINST A THIRD PARTY OR THAT A PATENT WILL ISSUE OR ANY PATENT WILL BE PROSECUTED OR MAINTAINED.
THIS SECTION 6.14 DOES NOT SUPERSEDE, MODIFY OR NEGATE ANY REPRESENTATION OR WARRANTY
EXPRESSLY MADE BY NXP IN THE SHARE EXCHANGE AGREEMENT.
6.15 Third Party Beneficiary Rights. Other than Subsidiaries and members of the Dutch
Newco Group, no provisions of this Agreement are intended, nor shall be interpreted, to
20
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
provide or create any third party beneficiary rights or any other rights of any kind in any
client, customer, employee, affiliate, stockholder, partner of any party hereto or any other Person
unless specifically provided otherwise herein and, except as so provided, all provisions hereof
shall be personal solely between the parties to this Agreement, except that Section 6.11 is
intended to benefit the Divested Entities.
6.16 Section 365(n). All rights and licenses granted under or pursuant to this
Agreement are, and will otherwise be, for purposes of Section 365(n) of Title 11, U.S. Code (the
“Bankruptcy Code”), licenses of rights to “intellectual property” as defined in the
Bankruptcy Code. The parties agree that Licensee and its Affiliates will retain and may fully
exercise all of its and their rights and elections under the Bankruptcy Code. All rights, powers
and remedies of Licensee and its Affiliates provided under this Section 6.16 are in
addition to, and not in substitution for, any and all other rights, powers and remedies now or
hereafter existing at law or in equity in the event of any commencement of a bankruptcy proceeding
by or against the Licensor.
6.17 Export Control. A Licensee shall comply with all applicable export control Laws
in its use of the Licensor’s software and technology, and, in particular, a Licensee shall not
export or re-export the Licensor’s software and technology without all required United States and
foreign government licenses. A Licensor shall reasonably cooperate with any written requests from a Licensee to provide information solely in the Licensor’s possession to assist
a Licensee in determining where any licenses are required with respect to the Licensor’s software
and technology.
21
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
IN WITNESS WHEREOF, this Agreement has been signed on behalf of each of the parties hereto as
of the date first written above.
NXP |
||||
By | /s/ Guido Diereck | |||
Name: Guido Diereck | ||||
Title: Authorized Signatory | ||||
NXP HOLDING 1 B.V. |
||||
By | /s/ Guido Diereck, Xxxx Xxxxxxxx | |||
Name: Guido Diereck, Xxxx Xxxxxxxx | ||||
Title: Authorized Signatory | ||||
Signature Page for IPTLA
CONFIDENTIAL
TREATMENT REQUESTED — REDACTED COPY
GUARANTEE
Trident Microsystems, Inc., a corporation organized under the laws of the State of Delaware,
hereby irrevocably and unconditionally guarantees to NXP B.V. the full and timely performance by
NXP Holding 1 B.V. of its obligations under the foregoing Intellectual Property Transfer and
License Agreement, and agrees to take all actions, and cause its direct and indirect subsidiaries
to take all actions which NXP Holding 1 B.V. is obligated to take under the Intellectual Property
Transfer and License Agreement. This Guarantee shall take effect as of the Closing.
Trident Microsystems, Inc. |
||||
By | /s/ Xxxxxx Xxxxxxx Couder | |||
Name: Xxxxxx Xxxxxxx Xxxxxx | ||||
Title: CEO Trident Microsystems |